The use of anti-CD20 chimeric monoclonal antibody, rituximab in adult patients with treatment refractory immune thrombocytopenia

被引：0
|
作者：
Jacoub, J
Mchlayeh, W
Tabbara, I
Dave, HP
Siegel, R
Schechter, GP
机构：
[1] George Washington Univ, Washington, DC USA
[2] Vet Affairs Med Ctr, Washington, DC USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3950
引用
收藏
页码：74B / 74B
页数：1
相关论文
共 50 条
  • [1] A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia
    Saleh, MN
    Gutheil, J
    Moore, M
    Bunch, PW
    Butler, J
    Kunkel, L
    Grillo-López, AJ
    LoBuglio, AF
    SEMINARS IN ONCOLOGY, 2000, 27 (06) : 99 - 103
  • [2] Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura
    Brændstrup, P
    Bjerrum, OW
    Nielsen, OJ
    Jensen, BA
    Clausen, NT
    Hansen, PB
    Andersen, I
    Schmidt, K
    Andersen, TM
    Peterslund, NA
    Birgens, HS
    Plesner, T
    Pedersen, BB
    Hasselbalch, HC
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (04) : 275 - 280
  • [3] Treatment of thrombocytopenia in refractory Evan's syndrome with anti-CD20 monoclonal antibody (Rituximab).
    Baltathakis, I
    Kakkas, I
    Karkatitaris, C
    Papasavvas, PL
    Tsionos, K
    BLOOD, 2002, 100 (11) : 82B - 82B
  • [4] Rituximab chimeric anti-CD20 monoclonal antibody treatment for refractory hemolytic anemia in patients with lymphoproliferative disorders
    Trapè, G
    Fianchi, L
    Lai, M
    Laurenti, L
    Piscitelli, R
    Leone, G
    Pagano, L
    HAEMATOLOGICA, 2003, 88 (02) : 223 - 225
  • [5] Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab)
    Marzano, Angelo V.
    Fanoni, Daniele
    Venegoni, Luigia
    Berti, Emilio
    Caputo, Ruggero
    DERMATOLOGY, 2007, 214 (04) : 310 - 318
  • [6] Anti-CD20 chimeric monoclonal antibody (rituximab) treatment of immune-mediated thrombocytopenia associated with Crohn's disease
    Papadakis, KA
    Rosenbloom, B
    Targan, SR
    GASTROENTEROLOGY, 2003, 124 (02) : 583 - 583
  • [7] Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody)
    Dupuy, A
    Viguier, M
    Bédane, C
    Cordoliani, F
    Blaise, S
    Aucouturier, F
    Bonnetblanc, JM
    Morel, P
    Dubertret, L
    Bachelez, H
    ARCHIVES OF DERMATOLOGY, 2004, 140 (01) : 91 - 96
  • [8] Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with refractory idiopathic thrombocytopenic purpura.
    Braendstrup, P
    Pedersen, M
    Bjerrum, OW
    Nielsen, OJ
    Jensen, BA
    Clausen, NT
    Hansen, PB
    Andersen, I
    Schmidt, K
    Andersen, TM
    Peterslund, NA
    Birgens, HS
    Plesner, T
    Pedersen, BB
    Hasselbalch, HC
    BLOOD, 2003, 102 (11) : 298A - 298A
  • [9] Treatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab
    Weitz, IC
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (02) : 138 - 141
  • [10] Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab)
    Arzoo, K
    Sadeghi, S
    Liebman, HA
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (10) : 922 - 924
12345